Edgestream Partners, L.P. Moderna, Inc. Transaction History
Edgestream Partners, L.P.
- $3.48 Billion
- Q2 2025
A detailed history of Edgestream Partners, L.P. transactions in Moderna, Inc. stock. As of the latest transaction made, Edgestream Partners, L.P. holds 100,730 shares of MRNA stock, worth $2.87 Million. This represents 0.08% of its overall portfolio holdings.
Number of Shares
100,730
Previous 97,961
2.83%
Holding current value
$2.87 Million
Previous $2.78 Million
0.07%
% of portfolio
0.08%
Previous 0.1%
Shares
7 transactions
Others Institutions Holding MRNA
# of Institutions
861Shares Held
267MCall Options Held
28.5MPut Options Held
34.8M-
Vanguard Group Inc Valley Forge, PA41.7MShares$1.19 Billion0.02% of portfolio
-
Black Rock Inc. New York, NY25.6MShares$728 Million0.07% of portfolio
-
Baillie Gifford & CO22.1MShares$629 Million0.48% of portfolio
-
State Street Corp Boston, MA17.3MShares$492 Million0.02% of portfolio
-
Geode Capital Management, LLC Boston, MA8.88MShares$253 Million0.02% of portfolio
About Moderna, Inc.
- Ticker MRNA
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 391,200,000
- Market Cap $11.1B
- Description
- Moderna, Inc., a biotechnology company, discovers, develops, and commercializes messenger RNA therapeutics and vaccines for the treatment of infectious diseases, immuno-oncology, rare diseases, cardiovascular diseases, and auto-immune diseases in the United States, Europe, and internationally. Its respiratory vaccines include COVID-19, flu, resp...